Benefits of β-Blocker Therapy for Heart Failure
نویسندگان
چکیده
منابع مشابه
Contraindicated initiation of β-blocker therapy in patients hospitalized for heart failure.
Author Contributions: All authors had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. Study concept and design: Lam and Steinman. Acquisition of data: Steinman. Analysis and interpretation of data: Lam, Miao, and Steinman. Drafting of the manuscript: Lam. Critical revision of the manuscript for important intel...
متن کاملThe Benefits of Yoga Therapy for Heart Failure Patients
THE BENEFITS OF YOGA THERAPY FOR HEART FAILURE PATIENTS by Paula R. Pullen STATEMENT OF THE PROBLEM The number of patients living with heart failure (HF) is on the rise. Yoga has been found to improve physical and psychological parameters amongst healthy individuals. The effects of yoga on HF patients are unknown. The purpose of this study was to examine the effects of yoga on cardio-vascular e...
متن کاملNew advances in beta-blocker therapy in heart failure
The use of β-blockers (BB) in heart failure (HF) has been considered a contradiction for many years. Considering HF simply as a state of inadequate systolic function, BB were contraindicated because of their negative effects on myocardial contractility. Nevertheless, evidence collected in the past years have suggested that additional mechanisms, such as compensatory neuro-humoral hyperactivatio...
متن کاملSoluble concentrations of the interleukin receptor family member ST2 and β-blocker therapy in chronic heart failure.
BACKGROUND Concentrations of soluble (s)ST2 predict prognosis in heart failure. We recently found changing doses of β-blocker (BB) may affect sST2 concentrations. It remains unclear whether sST2 concentrations identify benefit of BB therapy, however. METHODS AND RESULTS A total of 151 subjects with heart failure attributable to left ventricular systolic dysfunction were examined in this post ...
متن کاملCombined oral positive inotropic and beta-blocker therapy for treatment of refractory class IV heart failure.
OBJECTIVES We sought to assess the effects of combined oral positive inotropic and beta-blocker therapy in patients with severe heart failure. BACKGROUND Patients with severe, class IV heart failure who receive standard medical therapy exhibit a 1-year mortality rate >50%. Moreover, such patients generally do not tolerate beta-blockade, a promising new therapy for chronic heart failure. Posit...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Archives of Internal Medicine
سال: 2002
ISSN: 0003-9926
DOI: 10.1001/archinte.162.6.641